Irritable bowel syndrome with constipation (IBS-C) is a type of IBS, a condition that causes different digestive symptoms. The main symptom of IBS-C is constipation, with infrequent, hardened bowel ...

Funds will support one of the largest interventional clinical trials of a full-spectrum microbiome product, and the largest ever to be conducted in IBSDosing of first patient of the Phase 2b ‘RISE’ ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns ...

How Fiber Works in Your Body How Fiber Helps IBS-C What About FODMAPs? Fiber Supplements Best Fiber-Filled Foods Fiber is a must for regular bowel movements. But if you have irritable bowel syndrome ...

Q: I was diagnosed with IBS and feel like that basically means no one knows what’s going on. I’ve seen people recommend ...

After determining that a consultation is required (or directly requested by the patient), the next step is to identify what type of consultation is needed. Many patients are appropriately referred ...

IBS types are based on the symptoms you have. There are three main types of irritable bowel syndrome (IBS), based on whether you experience diarrhea, constipation, or both. Symptoms can range from ...

The prevalence of irritable bowel syndrome (IBS) and chronic idiopathic constipation among US adults rose significantly during the COVID-19 pandemic, with a near doubling of the national rate of IBS ...

Please provide your email address to receive an email when new articles are posted on . Nearly 80% of patients with irritable bowel syndrome and constipation improved with tenapanor at 12 weeks. The ...

SAN DIEGO -- The oral full-spectrum microbiome drug EBX-102-02 was well tolerated with mostly mild gastrointestinal adverse events and a trend toward less patient-reported pain and straining in those ...

A biopharmaceutical company that is developing microbiome therapies for gut health has completed a £19m round of financing to initiate the next phase of a clinical trial for ...

Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today ...